DGX vs MTUS · P/E 22, rev $5.94B vs P/E 279, rev $649.3M
Quest Diagnostics Incorporated (DGX) versus Metallus, Inc (MTUS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Metallus, Inc (MTUS) is a steel company listed on NYSE.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported MTUS revenue for 2026-06-30 was $649.3M. Net income was $14.3M. MTUS currently screens at market cap $814.2M and trailing P/E 279.4.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. MTUS currently screens at market cap $814.2M and trailing P/E 279.4.
Not investment advice. Open the DGX and MTUS stock pages for the full models.
Not investment advice.